A Comparative Study of an Innovative 3-lead Wireless Water Resistant Holter System and a Conventional Holter System
Primary Purpose
Cardiac Arrhythmia
Status
Completed
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
An innovative 3-lead wireless water resistant Holter device
A conventional device
Sponsored by
About this trial
This is an interventional diagnostic trial for Cardiac Arrhythmia
Eligibility Criteria
Inclusion Criteria:
- Any individual who has an indication of 24 hours Holter monitoring and is referred to the arrhythmia clinic of the Instituto Dante Pazzanese de Cardiologia
Exclusion Criteria:
- Refusal to provide written informed consent
Sites / Locations
- Instituto Dante Pazzanese de Cardiologia
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Holter device
Arm Description
In this single arm of the study, the participant will use 2 Holter systems simultaneously for 24 hours, an innovative 3-lead wireless water resistant device and a conventional device.
Outcomes
Primary Outcome Measures
Detection of cardiac arrhythmias
Number of patients with cardiac arrhythmias detected in both Holter monitors, including a) atrial fibrillation or atrial flutter; b) supraventricular tachycardia (≥ 3 beats); c) ventricular tachycardia (≥ 3 beats); d) polymorphic ventricular tachycardia or ventricular fibrillation; e) atrioventricular (AV) block (2nd degree AV block Mobitz type I and II, AV block 2:1 or complete AV block); or f) heart beat pauses (≥ 2,5 seconds)
Secondary Outcome Measures
Detection of atrial fibrillation or atrial flutter
Number of patients with atrial fibrillation or atrial flutter detected in both Holter monitors
Detection of supraventricular tachycardia
Number of patients with supraventricular tachycardia (≥ 3 beats) detected in both Holter monitors
Detection of ventricular tachycardia
Number of patients with ventricular tachycardia (≥ 3 beats) detected in both Holter monitors
Detection of polymorphic ventricular tachycardia or ventricular fibrillation
Number of patients with polymorphic ventricular tachycardia or ventricular fibrillation detected in both Holter monitors
Detection of atrioventricular block
Number of patients with atrioventricular block, including 2nd degree AV block Mobitz type I and II, AV block 2:1 or complete AV block, detected in both Holter monitors
Detection of heart beat pauses
Number of patients with heart beat pauses ≥ 2.5 seconds detected in both Holter monitors
Duration of the Holter exam
Duration of the Holter exam in both Holter monitors
Medium heart rate
Medium heart rate measured in both Holter monitors
Maximum heart rate
Maximum heart rate measured in both Holter monitors
Minimum heart rate
Minimum heart rate measured in both Holter monitors
Atrial ectopic heart beats
Total number of atrial ectopic heart beats measured in both Holter monitors
Ventricular ectopic heart beats
Total number of ventricular ectopic heart beats measured in both Holter monitors
Episodes of ventricular tachycardia
Total number of ventricular tachycardia episodes detected in both Holter monitors
Episodes of supraventricular tachycardia
Total number of supraventricular tachycardia episodes detected in both Holter monitors
Episodes of heart beat pauses
Total number of heart beat pauses ≥ 2.5 seconds detected in both Holter monitors
Holter system convenience of use
Patient self-reported evaluation of convenience of using each of the Holter monitors
Full Information
NCT ID
NCT04723355
First Posted
January 19, 2021
Last Updated
September 8, 2022
Sponsor
Hospital Israelita Albert Einstein
Collaborators
Instituto Dante Pazzanese de Cardiologia, Quoretech
1. Study Identification
Unique Protocol Identification Number
NCT04723355
Brief Title
A Comparative Study of an Innovative 3-lead Wireless Water Resistant Holter System and a Conventional Holter System
Official Title
A Comparative Study of the Findings of Dynamic Electrocardiography (Holter System) Using the an Innovative 3-lead Wireless Water Resistant Device and a Conventional Device
Study Type
Interventional
2. Study Status
Record Verification Date
February 2022
Overall Recruitment Status
Completed
Study Start Date
January 26, 2021 (Actual)
Primary Completion Date
November 16, 2021 (Actual)
Study Completion Date
November 16, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospital Israelita Albert Einstein
Collaborators
Instituto Dante Pazzanese de Cardiologia, Quoretech
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Holter monitoring is one of the most widely used diagnostic methods to detect cardiac arrhythmias. Newer Holter monitors may provide some advantages over the more traditional ones. This study will compare the findings of a Holter exam using an innovative 3-lead wireless water resistant device with a conventional device.
Detailed Description
The 24-hour ambulatory electrocardiography, commonly known as Holter monitoring, is a diagnostic method to correlate clinical symptoms with cardiac arrhythmias. The Holter monitor records electrical signals from the heart using electrodes attached to the chest, which are connected via cables to a digital recorder. In addition to the device to record the cardiac electrical signals, the Holter system also has a software for review and analysis of the record. The software of the Holter system has an integrated automatic analysis process to detect different sorts of heart beats, rhythms, etc, which are then validated by a technician and a physician. The success of the automatic analysis depends of the quality of the captured electrical signals, which are dependent on the appropriate attachment of the electrodes/cables to the patient body. Therefore, inappropriately attached electrodes/cables can result in electromagnetic disturbance that can interfere with the ECG signal, resulting in a very noisy record that is hard to be analysed.
Newer Holter systems that eliminate the cables and attach the recorder directly to the electrodes positioned in the patient´s chest might reduce the electromagnetic disturbance in the ECG signal capture and, therefore, improve the quality of the exam.
This study will compare the findings of a Holter exam using an innovative 3-lead wireless water resistant device with a conventional device.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiac Arrhythmia
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
231 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Holter device
Arm Type
Experimental
Arm Description
In this single arm of the study, the participant will use 2 Holter systems simultaneously for 24 hours, an innovative 3-lead wireless water resistant device and a conventional device.
Intervention Type
Device
Intervention Name(s)
An innovative 3-lead wireless water resistant Holter device
Intervention Description
The participant will use the innovative 3-lead wireless water resistant Holter device simultaneously with the conventional Holter device for 24 hours.
Intervention Type
Device
Intervention Name(s)
A conventional device
Intervention Description
The participant will use the innovative 3-lead wireless water resistant Holter device simultaneously with the conventional Holter device for 24 hours.
Primary Outcome Measure Information:
Title
Detection of cardiac arrhythmias
Description
Number of patients with cardiac arrhythmias detected in both Holter monitors, including a) atrial fibrillation or atrial flutter; b) supraventricular tachycardia (≥ 3 beats); c) ventricular tachycardia (≥ 3 beats); d) polymorphic ventricular tachycardia or ventricular fibrillation; e) atrioventricular (AV) block (2nd degree AV block Mobitz type I and II, AV block 2:1 or complete AV block); or f) heart beat pauses (≥ 2,5 seconds)
Time Frame
24 hours
Secondary Outcome Measure Information:
Title
Detection of atrial fibrillation or atrial flutter
Description
Number of patients with atrial fibrillation or atrial flutter detected in both Holter monitors
Time Frame
24 hours
Title
Detection of supraventricular tachycardia
Description
Number of patients with supraventricular tachycardia (≥ 3 beats) detected in both Holter monitors
Time Frame
24 hours
Title
Detection of ventricular tachycardia
Description
Number of patients with ventricular tachycardia (≥ 3 beats) detected in both Holter monitors
Time Frame
24 hours
Title
Detection of polymorphic ventricular tachycardia or ventricular fibrillation
Description
Number of patients with polymorphic ventricular tachycardia or ventricular fibrillation detected in both Holter monitors
Time Frame
24 hours
Title
Detection of atrioventricular block
Description
Number of patients with atrioventricular block, including 2nd degree AV block Mobitz type I and II, AV block 2:1 or complete AV block, detected in both Holter monitors
Time Frame
24 hours
Title
Detection of heart beat pauses
Description
Number of patients with heart beat pauses ≥ 2.5 seconds detected in both Holter monitors
Time Frame
24 hours
Title
Duration of the Holter exam
Description
Duration of the Holter exam in both Holter monitors
Time Frame
24 hours
Title
Medium heart rate
Description
Medium heart rate measured in both Holter monitors
Time Frame
24 hours
Title
Maximum heart rate
Description
Maximum heart rate measured in both Holter monitors
Time Frame
24 hours
Title
Minimum heart rate
Description
Minimum heart rate measured in both Holter monitors
Time Frame
24 hours
Title
Atrial ectopic heart beats
Description
Total number of atrial ectopic heart beats measured in both Holter monitors
Time Frame
24 hours
Title
Ventricular ectopic heart beats
Description
Total number of ventricular ectopic heart beats measured in both Holter monitors
Time Frame
24 hours
Title
Episodes of ventricular tachycardia
Description
Total number of ventricular tachycardia episodes detected in both Holter monitors
Time Frame
24 hours
Title
Episodes of supraventricular tachycardia
Description
Total number of supraventricular tachycardia episodes detected in both Holter monitors
Time Frame
24 hours
Title
Episodes of heart beat pauses
Description
Total number of heart beat pauses ≥ 2.5 seconds detected in both Holter monitors
Time Frame
24 hours
Title
Holter system convenience of use
Description
Patient self-reported evaluation of convenience of using each of the Holter monitors
Time Frame
24 hours
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Any individual who has an indication of 24 hours Holter monitoring and is referred to the arrhythmia clinic of the Instituto Dante Pazzanese de Cardiologia
Exclusion Criteria:
Refusal to provide written informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Karla Santo, PhD
Organizational Affiliation
Hospital Israelita Albert Einstein
Official's Role
Study Director
Facility Information:
Facility Name
Instituto Dante Pazzanese de Cardiologia
City
São Paulo
Country
Brazil
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
Individual participant data will be shared upon review of a request.
Learn more about this trial
A Comparative Study of an Innovative 3-lead Wireless Water Resistant Holter System and a Conventional Holter System
We'll reach out to this number within 24 hrs